By Lynne Peeples
PHOENIX—A new evidence-based algorithm can assist providers in determining the proper management of central venous access devices (CVADs) and, thereby, potentially better address or prevent any resulting skin damage in their patients. The tool was described at a session this week at the National Home Infusion Association Annual Conference.